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Editor’s key points
† The hypothesis that N2O
administration decreases
the amount of propofol
and remifentanil required
to maintain a specific
bispectral index (BIS) was
tested.
† N2O did not reduce
propofol and remifentanil
requirements in men
during BIS-guided
anaesthesia.
† N2O has a non-clinically
significant sparing effect
on propofol and
remifentanil in women.
Background. Nitrous oxide (N2O) offers both hypnotic and analgesic characteristics. We
therefore tested the hypothesis that N2O administration decreases the amount of propofol
and remifentanil given by a closed-loop automated controller to maintain a similar
bispectral index (BIS).
Methods. In a randomized multicentre double-blind study, patients undergoing elective
surgery were randomly assigned to breathe 60% inspired N2O (N2O group) or 40% oxygen
(AIR group). Anaesthesia depth was evaluated by the proportion of time where BIS was
within the range of 40–60 (BIS40 – 60). The primary outcomes were propofol and remifentanil
consumption, with reductions of 20% in either being considered clinically important.
Results. A total of 302 patients were randomized to the N2O group and 299 to the AIR group.
At similar BIS40 – 60 [79 (67–86)% vs 76 (65–85)%], N2O slightly decreased propofol
consumption [4.5 (3.7–5.5) vs 4.8 (4.0–5.9) mg kg21 h21, P¼0.032], but not remifentanil
consumption [0.17 (0.12–0.23) vs 0.18 (0.14–0.24) mg kg21 min21]. For the subgroups of
men, at similar BIS40 – 60 [80 (72–88)% vs 80 (70–87)%], propofol [4.2 (3.4–5.3) vs 4.4
(3.6–5.4) mg kg21 h21] and remifentanil [0.19 (0.13–0.25) vs 0.18 (0.15–0.23) mg kg21
min21] consumptions were similar in the N2O vs AIR group, respectively. For the subgroups
of women, at similar BIS40 – 60 [76 (64–84)% vs 72 (62–82)%], propofol [4.7 (4.0–5.8) vs 5.3
(4.5–6.6) mg kg21 h21, P¼0.004] and remifentanil [0.18 (0.13–0.25) vs 0.20 (0.15–0.27) mg
kg21 min21, P¼0.029] consumptions decreased with the co-administration of N2O.
Conclusions. With automated drug administration titrated to comparable BIS, N2O only
slightly reduced propofol consumption and did not reduce remifentanil consumption. There
was a minor gender dependence, but not by a clinically important amount.
Clinical trialregistration.This study was registered at ClinicalTrials.gov, number NCT00547209.
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Nitrous oxide (N2O) is a reliable short-acting, well-tolerated,
and inexpensive anaesthetic gas. N2O is not potent enough
to be used as a sole agent, but is commonly used as an
adjunct to balance volatile or i.v. general anaesthesia; it has
a hypnotic action mediated by the N-methyl-D-aspartate
subtype of glutamate receptors. Moreover, N2O has an anal-
gesic effect because it acts as a supraspinal opioid agonist in
the periaqueductal grey matter and activates noradrenergic
neurones in the locus coeruleus which project to a1 and a2
adrenoreceptors within the dorsal horn of the spinal cord.1
Themost obvious advantage of addingN2O to an anaesthetic
regimen is a reduction in hypnotic and opioid consumption. For
example, the use of N2O reduced propofol induction dose by
44%,2 reduced the propofol concentration required to avoid a
response to a surgical stimuli by 30%,3 and reduced propofol
consumption during general anaesthesia maintenance by
15–25%.4 5 Other studies report that adding N2O produces a
clinical benefit similar to a remifentanil infusion of 0.085 mg
kg21 min21 during desflurane anaesthesia guided by the BIS6
or 0.17mg kg21 min21 during isoflurane inhalation.7 A limitation
of these studies is that propofol administration was adjusted
manuallybyunblindedinvestigators inaccordancewithhaemo-
dynamic and clinical criteria.3 –7
An alternative to haemodynamic and clinical criteria for drug
administration during general anaesthesia is titration to electro-
cortical activity measured by the bispectral index (BIS) monitor
(Covidien, Dublin, Ireland).8 There are reports showing that, in
the absence of noxious stimuli, BIS is not affected by N2O inhal-
ation in volunteers9 or patients.10–13 Moreover, several studies
showed a poor relationship between clinical sedation scales
and the BIS during sedation of volunteers14 and adult15 16 or
paediatric17 patients. However, N2O as an anaesthetic adjuvant
modifies electrocortical activation during surgery18 and the
response to noxious stimuli such as laryngoscopy during volatile
anaesthesia.19 Furthermore, electrocortical activity is a function
of anaesthetic depthduringsurgery20 and inresponse tonoxious
stimuli.19 21 22 There is only slight evidence that N2O does not
affect BIS values during maintenance of general anaesthesia.
Studies related to the influence of N2O on BIS values were
performed on volunteers9 during induction10 and the number
of patients studied during surgery was limited.11–13 The extent
to which N2O spares i.v. anaesthetics or modifies BIS values
during maintenance of general anaesthesia thus remains
unclear.
We have developed a closed-loop controller allowing auto-
mated titration of propofol and remifentanil solely guided
by the BIS. An automated controller of drug delivery is an
unbiased assessment of anaesthetic requirements when an
adjunct is used.23 We used this objective system in a rando-
mized controlled multicentre trial to determine the sparing
effect of 60% N2O on propofol or remifentanil consumption
during maintenance of general anaesthesia. Specifically, we
tested the primary hypothesis that N2O administration
decreases the amount of propofol and remifentanil given by
our closed-loop controller to maintain a similar BIS index.
Our secondary hypothesis, added at the request of the
German Ethics Committee, was that there is an interaction
between gender and the drug-sparing effect of N2O.
Methods
Study population
Our prospective multicentre randomized double-blind clinical
trial was approved by the Ethics Committees of the participat-
ing French (Comite´ Consultatif de Protection des Personnes
dans la Recherche Biome´dicale, Hoˆpital A. Pare´, Boulogne
Billancourt, France), Belgian (Comite´ d’Ethique hospitalo-
facultaire Erasme-ULB, Brussels, Belgium), and German univer-
sities (Ethikkommission der Charite´-Universita¨tsmedizin,
Berlin, Germany). It was also approved by the French national
regulatory office (Agence Franc¸aise de Se´curite´ Sanitaire des
Produits de Sante´). This study was registered at ClinicalTrials.-
gov, number NCT00547209.
Written informed consent was obtained during the preopera-
tive visit performed by the investigators. Patients undergoing
elective surgery (vascular, general, orthopaedic, gynaecological,
urological, otolaryngological) requiring general anaesthesia
without combined regional/general anaesthesia expected to
last more than 60 min and requiring tracheal intubation were
enrolled at 10 university, general, or private hospitals: Hoˆpital
Foch (Suresnes), Centre Hospitalier Victor Dupouy (Argenteuil),
Centre Hospitalo-Universitaire of Besanc¸on and Tours, Clinique
Saint Augustin (Bordeaux), La Baie des Citrons (Noume´a)
New Caledonia, ULB-Erasme (Brussels) Belgium, and Charite´-
Universitaetsmedizin Berlin (Berlin) Germany. Patients were
aged 18–80 yr and ASA physical status I–IV. Exclusion criteria
included cranial procedures, psychiatric illness, supraspinal
neurological disorders, and patients equipped with a pacemaker.
Moreover, patients undergoing thoracic or cardiac surgery were
excluded due to possible occurrence of hypoxaemia or gas
embolism, respectively.
Procedures
All patients received a propofol and remifentanil infusion con-
trolled by our automated closed-loop system during induction
and maintenance of general anaesthesia.8 All investigators
received a full day of training in the use of the automated con-
troller at the Hoˆpital Foch, Suresnes, France.
On arrival in the theatre, a dedicated i.v. cannula was
inserted, routine monitoring commenced including tempera-
ture. Neuromuscular function at the adductor pollicis was mon-
itored after loss of consciousness. A BIS electrode (Zipprep,
Covidien) was positioned on the patient’s forehead and con-
nected to either an A-2000 XP (version 3.11) BIS monitor or a
BIS M-Module (GE-Healthcare S/5TM, Helsinki, Finland).
The controller8 was implemented using Infusion Toolbox 95w
version 4.11 software24 which served as a platform: (i) to calcu-
late effect-site concentrations of propofol and remifentanil
using the pharmacokinetic population of Schnider and collea-
gues25 and Minto and colleagues26 for propofol and remifenta-
nil, respectively; (ii) to display these calculated effect-site
concentration estimates in real time; (iii) to provide a user
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interface that permits entry of patient characteristic data (sex,
age, weight, and height) and modification of upper and lower
limits of drug concentrations; (iv) to control the propofol and
remifentanil infusion pumps (Asena GHw, Alaris Medical, Hamp-
shire, UK); and (v) recording BIS, calculated effect-site concen-
trations, and haemodynamic data when an AS/5TM monitor
was used. In both groups, the investigator chose the initial pro-
pofol effect-site target concentration according to his/herclinic-
al judgement and the controller fixed the first remifentanil
effect-site target concentration. In both groups, patients
received total i.v. anaesthesia in target-controlled infusion
mode using the automated controller of propofol and remifen-
tanil. Patients received a neuromuscular blocking agent to facili-
tate tracheal intubation.
The controller has a cascade structure including a dual
proportional-integral-derivative algorithm and a target-
controlled infusion system for the administration of i.v. anaes-
thetics. The controller uses the parameters from the BIS
monitor if the signal quality index is more than 50%. The
controller measures the electromyographic activity, the
percentage of burst suppression ratio (SR), and calculates
the BISerror or the difference between the set point of 50 and
the actual measured BIS value. If the BISerror is different from
0, the controller determines a new propofol, remifentanil,
or both concentrations. The controller increases or decreases
the drug concentration according to the BISerror sign. The
error size determines which drug will be modified: if the BISerror
is small, only the remifentanil is changed; if the BISerror is higher
than a threshold, the two drug concentrations are changed.
The minimal interval between two consecutive controls is set
equal to the time to peak effect of each drug; this time interval
is shorter for remifentanil26 than for propofol,25 thus remifen-
tanil modifications are made more frequently. The feed-
forward term gives the rate of change in the error and amplifies
every 5 s the correction of the drugs when a measured BISvalue
is. 60. The interaction rule between propofol and remifentanil
is as follows: if the controller successively increases the remi-
fentanil concentration more than three times, then the propo-
fol concentration is increased. A detailed description of the
controller has been provided in a previous controlled study.8
In the current study, the controller was identical for the thresh-
olds, rules, propofol gain constants, and lower and upper limits
of propofol (1.3 and 5 mg ml21) or remifentanil (3 and 12 ng
ml21) of the previous controller. Only the values of gain con-
stants for the remifentanil were decreased by15%. Throughout
the procedure, the investigator could adjust the lower or the
upper limits of propofol remifentanil when the BIS decreased
to and remained under 40.
Patients were allocated into two groups in a 1:1 ratio: the AIR
group in which the lungs were mechanically ventilated with
40% inspired oxygen fraction after tracheal intubation or the
N2O group in which the lungs were mechanically ventilated
using a mixture of 40% inspired oxygen fraction and 60%
of inspired N2O after tracheal intubation. Treatments were
segregated into blocks of 10 at each participating centre, and
randomization was determined using an online random
number generator just before anaesthesia induction. Other
than administration of the study drugs, patient management
wasbased on current standardsof care. No specific recommen-
dations were given for the treatment of haemodynamic
299 patients with completed data
(154 M/145 F)
302 patients with completed data
(157 M/145 F)
33 (10%) patients excluded:
13 Propofol lower limit too high
7 Increase propofol lower limit
7 Recording system failure
3 Artifact
2 Duration <1 h
1 Computer dysfunction
33 (10%) patients excluded:
13 Propofol lower limit too high
4 Increase propofol lower limit
4 Recording system failure
5 Artifact
4 Duration <1 h
1 Hypoxaemia
1 Pump dysfunction
1 Venous access dysfunction
686 patients approached
332 studied in AIR group 335 studied in N2O group
14 refused
672 randomized
Fig 1 Trial profile. M, male; F, female. N2O, patients were ventilated with 60% of nitrous oxide; AIR, patients were ventilated with 40% of oxygen.
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abnormalities and for the use of a neuromuscular blocking
agent. Approximately 45 min before the presumed end of
surgery, i.v. analgesics were given to provide postoperative
pain relief. Morphine, proparacetamol, nefopam, or non-
steroidal anti-inflammatory drugs were given at the discretion
of the physician. In both groups, propofol and remifentanil
were stopped simultaneously upon completion of surgery
and all patients were ventilated with 100% oxygen before tra-
cheal extubation.
The primary outcomes were propofol or remifentanil
consumption during maintenance of general anaesthesia.
Consumption was defined by drug requirement between the
start of mechanical ventilation and the end of drug infusion.
Secondary outcomes included the percentage of data points
with adequate anaesthesia, defined as BIS between 40 and
60 (BIS40 – 60), deep anaesthesia (BIS,40), and light anaesthesia
(BIS.60). Excessive anaesthesia was defined as the occurrence
of SR with SR .10% lasting at least 1 min.27 The number of
somatic events (i.e. movement, grimacing) was recorded.
Recall of intraoperative events was determined by a standar-
dized interview performed in the post-anaesthesia care unit
and on the second or third postoperative day.28 An analysis
related to the gender was performed upon request by the
German ethical committee.
Statistical analyses
In a previous study during maintenance of general anaesthesia,
propofol and remifentanil consumption were 4.7 (1.6) mg kg21
h21 and 0.22 (0.07) mg kg21 min21 using the dual-loop control-
ler.8 We anticipated that N2O administration would reduce pro-
pofol or remifentanil consumption by at least 20% and thus
estimated that a total of 144 patients per group would provide
a 95% power for a two-sideda-error of 1%. To provide adequate
power for the gender interaction analysis, we planned to recruit
680 patients under the assumption that some would be
excluded for various reasons.
Categorical variables, expressed as numbers and frequen-
cies, were compared using Fisher’s exact test as appropriate.
Continuous variables were described as the median and inter-
quartile range (IQR) and compared using the Mann–Whitney
U-test. The statistical analysis was performed in the overall
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Fig 2 Examples for the interpretation of automated control of propofol and remifentanil guided by the BIS. (A) Ninety-four per cent of anaesthesia
maintenance the BIS was adequate or in the range 40 and 60 (BIS40 – 60) or pink area in the upper figure. The propofol and remifentanil lower limits
were never reached. We can conclude that propofol and remifentanil titrations were performed correctly. (B) The BIS40 – 60 ¼26%, the pink area
represents a period of too deep anaesthesia, the lower limits of propofol (1.3mg ml21) and remifentanil (3 ng ml21) were reached and the controller
could not decrease the concentrations. This case was excluded from the analysis. (C) The BIS40 – 60 ¼37%, the pink area represents a period of too
deep anaesthesia, the lower propofol and remifentanil limits were increased (2 mg ml21 and 4 ng ml21, respectively) by the investigator and the
controller could not decrease the concentrations. This case was excluded from the analysis. Upper figure: BIS value. Lower figure: effect-site
concentration¼calculated effect-site concentration of propofol (mg ml21), or remifentanil (ng ml21); green dashed line, propofol and blue thick
line, remifentanil.
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populationandbygenderafterananalysisofvariancetest tode-
termine the interaction between propofol or remifentanil and
gender. Probability values of ,0.05 using two-tailed tests
were considered statistically significant. Data analysis was per-
formed using IBM-SPSSw version 20 (IBM-SPSS Science, Inc.,
Chicago, IL, USA).
Results
Among 686 patients who were approached, 672 were recruited
between January 2008 and June 2009. Usable data were
obtained from 299 patients in the AIR group and 302 patients
in the N2O group (Fig. 1). Different examples for the interpret-
ation of automated control are presented in Figure 2. Baseline
characteristics were similaras a function of N2O administration
and gender (Table 1). One-third of subjects took at least one
cardiovascular medication before operation. The median BIS
values from induction to propofol and remifentanil discontinu-
ation are presented in Figure 3. During induction, propofol
requirements were similar with N2O [1.1 (0.7–1.4) mg kg
21]
and AIR [1.0 (0.7–1.4) mg kg21, P¼0.51]; remifentanil require-
ments were also similar with N2O [1.8 (1.4–2.8) mg kg
21] and
AIR [1.8 (1.4–2.9) mg kg21, P¼0.48].
The lower limit of propofol wasdecreased more frequently in
the N2O group than in the AIR group (51% vs 34% of patients,
P,0.0001). The lower limit of remifentanil was decreased in
similar occurrence between the two groups (22% vs 17% of
patients, P¼0.18 N2O vs AIR respectively). N2O administration
significantly decreased propofol requirement by 6%, although
hypnotic effect as determined by the percentage of BIS40 – 60 or
procedure duration was similar (Fig. 4, Table 2).
The subgroups of women, N2Owomen (n¼145) and Airwomen
(n¼145), were well balanced with respect to demography,
morphometrics, and surgical procedure (Table 1). There was a
significant interaction between gender and anaesthetic: N2O
decreased propofol requirements by 11% (P¼0.004) and
remifentanil requirements by 14% (P¼0.029) in women, but
had almost no effect in men (Table 3, Fig. 4). Women, but not
men, were more likely to experience light anaesthesia
(BIS.60) during AIR than nitrous oxide administration
(Table 2). However, in the subgroup of men, N2O decreased
the occurrence of movements and hypertensive episodes
with antihypertensive therapy (Table 2). No cases of awareness
with recall were reported.
Discussion
Automated administration of anaesthetic drugs is objective
and, therefore, an appropriate method for evaluating the con-
tribution of anaesthetic adjuvants since clinician bias is elimi-
nated. This approach has consequently been used, for
example, to determine the sparing effect of N2O on the rocur-
onium requirement23 and the sparing effect of remifentanil on
propofol.29 The closed-loop approach that we used thus com-
pares favourably with previous studies in which the sparing
effects of N2O were evaluated by unblinded protocol and
depth of hypnosis or analgesia were evaluated by haemo-
dynamic criteria.3 – 7 Haemodynamic responses, in particular,
are poor indicators of hypnotic depth and influenced by
painful stimulation, to say nothing of chronic hypertension
and various treatments, blood loss, fluid administration, vaso-
pressor use, heart failure, arrhythmia, and manipulation of
great vessels. Our primary result is that in our study population,
which was roughly balanced among men and women, N2O
reduced propofol consumption by only 6%. While statistically
significant, this small reduction is not clinically important.
Gender differences have been reported for various aspects
of anaesthesia care, including postoperative nausea and
vomiting30 or postoperative pain intensity.31 Women require
more propofol than men during maintenance of general
anaesthesia32 and wake up faster.33 – 35 Curiously, gender
differences have yet to be reported for N2O, although they
may explain apparent discrepancies in reported electrophysio-
logical effects of N2O. For example, N2O alone increased the
b and u or excitatory electrocortical activity in a volunteer
study in which the sex ratio was well balanced.9 In contrast,
N2O increased dactivity or central inhibitory action in a surgical
patient study in which 14 of 15 patients were female.18 Our
results show that the effect of nitrous oxide on anaesthetic
requirement differed as a function of gender, with nearly
all the observed sparing being in women. Furthermore, N2O
decreased light anaesthesia or BIS.60 only in women. The
interaction between N2O and drug sparing by gender was
Table 1 Characteristics of patients at entry. Data presented as
medians (IQR), or number (%). N2O, patients were ventilated with
60% of nitrous oxide; AIR, patients were ventilated with 40% of
oxygen. Preoperative cardiovascular treatment including
b-blockers, calcium channel blockers, angiotensin-converting
enzyme inhibitors, or diuretics
N2O Air
Number of patients 302 299
Male 157 154
Female 145 145
Age (yr) 58 (46–67) 58 (44–71)
Male 60 (53–68) 61 (50–71)
Female 54 (44–65) 55 (41–69)
Height (cm) 170 (161–175) 170 (161–175)
Male 174 (170–180) 174 (170–178)
Female 163 (159–168) 162 (157–167)
Weight (kg) 72 (63–80) 73 (62–84)
Male 77 (69–83) 79 (71–88)
Female 66 (59–79) 65 (57–77)
ASA physical status III and IV 46 (15) 58 (19)
Male 29 (18) 39 (25)
Female 17 (12) 19 (13)
Cardiovascular treatment 87 (29) 101 (34)
Male 49 (31) 63 (41)
Female 38 (26) 38 (26)
Major surgery 115 (39) 128 (44)
Male 79 (51) 80 (53)
Female 36 (25) 48 (34)
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statisticallysignificant (Table 3); however, the effect is probably
not clinically relevant even in women. For example, the
propofol-sparing effect of 60% inspired N2O is only 39 mg
h21 and the remifentanil-sparing effect is only 78 mg h21 in a
woman weighing 65 kg. A study including stratification by
gender is probably necessary to give a definitive conclusion
of this difference. However, to detect a difference of 12% pro-
pofol consumption with a two-sided a-error of 5% and a
power of 80%, the minimum effect size of interest is 112
patients. In the current study, we included more than 145
patients per group (Table 1), thus power was adequate, and
the decrease in propofol consumption simply too small to be
clinically important.
Intraoperative movement is common (i.e. 60%) during
alfentanil and propofol anaesthesia, and the incidence is
halved by N2O administration.
36 Intraoperative movement
possibly results more from inadequate analgesia than inad-
equate hypnosis. N2O is analgesic; but at least in animals, its
analgesic action is to some degree dissociated from immobil-
ity.37 We found that N2O administration reduced movement
and hypertension only in men and this spinal action may be
clinically useful (Table 2). Finally, our study reported a suprasp-
inal activity of N2O in women reflected by the decrease in drug
requirements given by the controller, and a spinal activity of
N2O in men suggested by the decreased incidence of
hypertension and movements without the decrease in drug re-
quirement related to the absence of cortical activity changes.
Patients included in the current study underwent avarietyof
surgical procedures, in different centres, with different sur-
geons, which might have led to different noxious stimuli
levels. Unfortunately, we did not record, during the different
surgical procedures, the periods with or without noxious stimu-
lation for all patients. Moreover, we lack specific and robust
monitors for the quantification of noxious stimuli intensity.
The sparing effect of N2O on anaesthetic requirements is
related to the intensity of noxious stimuli19 22 and mediated
by an anti-nociceptive action such as provided by lidocaine.38
Probably, N2O is more effective for open rather than laparo-
scopic procedures, but the difference needs to be clinically rele-
vant during propofol–remifentanil anaesthesia.39 Indeed, to
obtain a desired BIS value, there are several combinations of
propofol–remifentanil ratios. But, in both groups, we used the
same controller, with the same reproducible titration method
for propofol and remifentanil and the results were related to
gain constants of the controller. Certainly, the results would
be different with another controller gain constant, with a
single closed loop of propofol with a continuous and fixed infu-
sion at different targets of remifentanil, or with a continuous
fixed infusion of propofol at different targets associated with
a single remifentanil closed-loop controller guided by BIS.
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However, the sparing effect of N2O would probably be ,20%
and not clinically relevant. Another limitation of our approach
is that N2O causes a degree of sympathetic activation which
activates electroencephalographic signals after noxious
stimuli.21 A consequence is that N2O decreases BIS less than
would be expected based on its MAC.9 A closed-loop system
controlled to another anaesthetic measure of anaesthesia
depth might well have identified a greater drug-sparing
effect of N2O. The difficulty, of course, is that there are few well-
validated measures of hypnotic effect that do not depend on
the electroencephalogram. We only evaluated the sparing
Table 2 Comparison of anaesthetic procedures during the maintenance phase. Data presented as medians (IQR), or number (%). N2O, patients
were ventilated with 60% of nitrous oxide; AIR, patients were ventilated with 40% of oxygen. Duration, duration of anaesthesia; SR, suppression
ratio; occurrence of SR was defined as SR value.10% lasting more than 1 min. BIS, bispectral index. BIS40 – 60, percentage of time in which the BIS
value was between 40 and 60 during the maintenance. BIS,40, percentage of time in which the BIS value was below a value of 40. BIS.60,
percentage of time in which the BIS value was greater than a value of 60
N2O Air P-value
Number of patients 302 299
Male 157 154
Female 145 145
Duration (min) 129 (83–187) 125 (84–200) 0.83
Male 143 (95–222) 139 (91–225) 0.70
Female 107 (80–148) 109 (70–165) 0.37
BIS40 – 60 (%) 79 (67–86) 76 (65–85) 0.30
Male 80 (72–88) 80 (70–87) 0.85
Female 76 (64–84) 72 (62–82) 0.20
BIS,40 (%) 15 (9–23) 16 (10–24) 0.71
Male 15 (9–23) 16 (10–24) 0.98
Female 21 (13–31) 23 (14–32) 0.58
BIS.60 (%) 3 (1–5) 4 (2–6) 0.001
Male 2 (1–5) 3 (2–5) 0.69
Female 3 (1–5) 4 (2–7) 0.005
Occurrence of SR 59 (20) 54 (18) 0.75
Male 37 (24) 32 (21) 0.69
Female 22 (15) 22 (15) 1
Propofol (mg kg21 h21) 4.5 (3.7–5.5) 4.8 (4.0–5.9) 0.032
Male 4.2 (3.4–5.3) 4.4 (3.6–5.4) 0.92
Female 4.7 (4.0–5.8) 5.3 (4.5–6.6) 0.004
Remifentanil (mg kg21 min21) 0.17 (0.12–0.23) 0.18 (0.14–0.24) 0.21
Male 0.19 (0.13–0.25) 0.18 (0.15–0.23) 0.58
Female 0.18 (0.13–0.25) 0.20 (0.15–0.27) 0.029
Movement 18 (6) 40 (13) 0.004
Male 6 (4) 21 (14) 0.005
Female 12 (8) 19 (13) 0.26
Anti-hypertensive therapy 21 (7) 46 (15) 0.005
Male 13 (8) 28 (18) 0.012
Female 8 (6) 18 (12) 0.063
Neuromuscular blockers 129 (43) 147 (49) 0.34
Male 73 (46) 85 (55) 0.43
Female 56 (39) 62 (43) 0.66
Ephedrine bolus 109 (36) 96 (32) 0.51
Male 58 (37) 47 (31) 0.43
Female 51 (35) 49 (34) 0.91
Table 3 Interaction of gender with propofol and remifentanil
consumption. Two-factors analysis of variance with interaction.
One fixed factor was the treatment (group) and one random factor
gender. DF, degree of freedom
Source DF F-ratio P-value
Propofol Group 1 1.13 0.48
Gender 1 56.3 ,0.0002
Remifentanil Group 1 1.11 0.48
Gender 1 37.5 ,0.0001
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effect on propofol and remifentanil consumption and not post-
operative morphine requirements. Specific studies are neces-
sary to determine if N2O can prevent hyperalgesia related to
remifentanil titrate by the BIS.40
In summary, N2O did not reduce propofol and remifentanil
requirements in men during BIS-guided anaesthesia. In con-
trast, N2O significantly spares propofol and remifentanil in
women—although the magnitude of the reduction is unlikely
to prove clinically important. Adding nitrous oxide to BIS-
guided closed-loop i.v. anaesthesia thus appears to provide
little benefit.
Authors’ contributions
N.L.: study design, conduct of the study, data analysis, and
manuscript preparation. M.L.G.: conduct of the study, data ana-
lysis, and manuscript preparation. N.B.: conduct of the study.
A.G.: conduct of the study. T.H.: conduct of the study. D.S.:
conduct of the study. G.K.: conduct of the study. A.L.: conduct
of the study. J.J.B.: conduct of the study. A.C.: conduct of the
study. J.B.: conduct of the study. B.R.: conduct of the study
and manuscript preparation. S.T.: conduct of the study. T.C.:
study design, conduct of the study, and data analysis. D.I.S.:
manuscript preparation. M.F.: study design and manuscript
preparation.
Declaration of interest
Support was provided by the Service d’Anesthe´sie, Hoˆpital
Foch, Suresnes, France, Vaincre la Mucoviscidose (Paris,
France), and by Alaris Medical (Hampshire, UK) who loaned
the Asena GH infusion pumps to the study. Hoˆpital Foch, N.L.,
and T.C. have a patent in France for the gain constants in the
control algorithm (No. BFF08P669, Institut National de la Pro-
prie´te´ Industrielle, France). None of the other authors has a
personal financial interest in this research.
References
1 Sanders RD, Weimann J, Maze M. Biologic effects of nitrous oxide: a
mechanistic and toxicologic review. Anesthesiology 2008; 109:
707–22
2 Ng JM, Hwang NC. Inhaling nitrous oxide reducesthe induction dose
requirements of propofol. Anesth Analg 2000; 90: 1213–6
3 Davidson JA, Macleod AD, Howie JC, White M, Kenny GN. Effective
concentration 50 for propofol with and without 67% nitrous
oxide. Acta Anaesthesiol Scand 1993; 37: 458–64
4 Sukhani R, Lurie J, Jabamoni R. Propofol for ambulatory gyneco-
logic laparoscopy: does omission of nitrous oxide alter post-
operative emetic sequelae and recovery? Anesth Analg 1994; 78:
831–5
5 Arellano RJ, Pole ML, Rafuse SE, et al.Omission of nitrous oxide from
a propofol-based anesthetic does not affect the recovery of women
undergoing outpatient gynecologic surgery. Anesthesiology 2000;
93: 332–9
6 Mathews DM, Gaba V, Zaku B, Neuman GG. Can remifentanil replace
nitrous oxide during anesthesia for ambulatory orthopedic
surgery with desflurane and fentanyl? Anesth Analg 2008; 106:
101–8
7 Lee LH, Irwin MG, Lui SK. Intraoperative remifentanil infusion does
not increase postoperative opioid consumption compared with
70% nitrous oxide. Anesthesiology 2005; 102: 398–402
8 Liu N, Chazot T, Hamada S, et al. Closed-loop coadministration of
propofol and remifentanil guided by bispectral index: a randomized
multicenter study. Anesth Analg 2011; 112: 546–57
9 Rampil IJ, Kim JS, Lenhardt R, Negishi C, Sessler DI. Bispectral EEG
index during nitrous oxide administration. Anesthesiology 1998;
89: 671–7
10 Barr G, Jakobsson JG, Owall A, Anderson RE. Nitrous oxide does not
alter bispectral index: study with nitrous oxide as sole agent and as
an adjunct to i.v. anaesthesia. Br J Anaesth 1999; 82: 827–30
11 Ozcan MS, Ozcan MD, Khan QS, Thompson DM, Chetty PK. Does
nitrous oxide affect bispectral index and state entropy when
added to a propofol versus sevoflurane anesthetic? J Neurosurg
Anesthesiol 2010; 22: 309–15
12 Soto RG, Smith RA, Zaccaria AL, Miguel RV. The effect of addition of
nitrous oxide to a sevoflurane anesthetic on BIS, PSI, and entropy.
J Clin Monit Comput 2006; 20: 145–50
13 Eilers H, Larson MD. The effect of ketamine and nitrous oxide on the
human pupillary light reflex during general anesthesia.AutonNeu-
rosci 2010; 152: 108–14
14 Hall DL, Weaver J, Ganzberg S, Rashid R, Wilson S. Bispectral EEG
index monitoring of high-dose nitrous oxide and low-dose sevoflur-
ane sedation. Anesth Prog 2002; 49: 56–62
15 Karalapillai D, Leslie K, Umranikar A, Bjorksten AR. Nitrous oxide and
anesthetic requirement for loss of response to command during
propofol anesthesia. Anesth Analg 2006; 102: 1088–93
16 Park KS, Hur EJ, Han KW, Kil HY, Han TH. Bispectral index does not
correlate with observer assessment of alertness and sedation
scores during 0.5% bupivacaine epidural anesthesia with nitrous
oxide sedation. Anesth Analg 2006; 103: 385–9
17 Isik B, Tuzuner T, Tezkirecioglu M, Oztas N. Nitrous oxide sedation
and bispectral index. Eur J Dent 2007; 1: 240–5
18 Avramov MN, Shingu K, Mori K. Progressive changes in electroence-
phalographic responses to nitrous oxide in humans: a possible
acute drug tolerance. Anesth Analg 1990; 70: 369–74
19 Oda Y, Tanaka K, Matsuura T, Hase I, Nishikawa K, Asada A. Nitrous
oxide induces paradoxical electroencephalographic changes after
tracheal intubation during isoflurane and sevoflurane anesthesia.
Anesth Analg 2006; 102: 1094–102
20 Henrie JR, Parkhouse J, Bickford RG. Alteration of human conscious-
ness by nitrous oxide as assessed electro-encephalography and
psychological tests. Anesthesiology 1961; 22: 247–59
21 Coste C, Guignard B, Menigaux C, Chauvin M. Nitrous oxide prevents
movement during orotracheal intubation without affecting BIS
value. Anesth Analg 2000; 91: 130–5
22 Hans P, Bonhomme V, Benmansour H, Dewandre PY, Brichant JF,
Lamy M. Effect of nitrous oxide on the bispectral index and the
95% spectral edge frequency of the electroencephalogram
during surgery. Anaesthesia 2001; 56: 999–1002
23 Illman H, Antila H, Olkkola KT. Quantitation of the effect of nitrous
oxide on rocuronium infusion requirements using closed-loop feed-
back control. Anesthesiology 2008; 108: 388–91
24 Cantraine FR, Coussaert EJ. The first object oriented monitor for
intravenous anesthesia. J Clin Monit Comput 2000; 16: 3–10
25 Schnider TW, Minto CF, Shafer SL, et al. The influence of age
on propofol pharmacodynamics. Anesthesiology 1999; 90:
1502–16
26 Minto CF, Schnider TW, Egan TD,et al. Influence of age and gender on
the pharmacokinetics and pharmacodynamics of remifentanil. I.
Model development. Anesthesiology 1997; 86: 10–23
BJA Liu et al.
850
27 Besch G, Liu N, Samain E, et al. Occurrence of and risk factors for
electroencephalogram burst suppression during propofol–remi-
fentanil anaesthesia. Br J Anaesth 2011; 107: 749–56
28 Leclerc C, Gerard JL, Bricard H. Intraoperative memory. A study of its
incidence in general anesthesia in 326 patients. Ann Fr Anesth
Reanim 2001; 20: 592–9
29 Milne SE, Kenny GN, Schraag S. Propofol sparing effect of remifenta-
nil using closed-loop anaesthesia. Br J Anaesth 2003; 90: 623–9
30 Apfel CC, Korttila K, Abdalla M, et al. A factorial trial of six interven-
tions for the prevention of postoperative nausea and vomiting. N
Engl J Med 2004; 350: 2441–51
31 Cepeda MS, Carr DB. Women experience more pain and require
more morphine than men to achieve a similar degree of analgesia.
Anesth Analg 2003; 97: 1464–8
32 Kreuer S, Biedler A, Larsen R, Altmann S, Wilhelm W. Narcotrend
monitoring allows faster emergence and a reduction of drug con-
sumption in propofol–remifentanil anesthesia. Anesthesiology
2003; 99: 34–41
33 Gan TJ, Glass PS, Sigl J, et al. Women emerge from general
anesthesia with propofol/alfentanil/nitrous oxide faster than
men. Anesthesiology 1999; 90: 1283–7
34 Buchanan FF, Myles PS, Cicuttini F. Effect of patient sex on general
anaesthesia and recovery. Br J Anaesth 2011; 106: 832–9
35 Hoymork SC, Raeder J. Why do women wake up faster than men
from propofol anaesthesia? Br J Anaesth 2005; 95: 627–33
36 Servin FS, Marchand-Maillet F, Desmonts JM. Influence of
analgesic supplementation on the target propofol concentra-
tions for anaesthesia with ‘Diprifusor’ TCI. Anaesthesia 1998;
53(Suppl. 1): 72–6
37 Jinks SL, Carstens E, Antognini JF. Nitrous oxide-induced analgesia
does not influence nitrous oxide’s immobilizing requirements.
Anesth Analg 2009; 109: 1111–6
38 Hans GA, Lauwick SM, Kaba A, et al. Intravenous lidocaine
infusion reduces bispectral index-guided requirements of
propofol only during surgical stimulation. Br J Anaesth 2010; 105:
471–9
39 Gibbs NM, Weightman WM. Beyond effect size: consideration of the
minimum effect size of interest in anesthesia trials. Anesth Analg
2012; 114: 471–5
40 Richebe P, Rivat C, Creton C, et al. Nitrous oxide revisited: evidence
for potent antihyperalgesic properties. Anesthesiology 2005; 103:
845–54
Handling editor: M. M. R. F. Struys
Nitrous oxide and i.v. anaesthesia BJA
851
